
r Sustained Release Oral Opioid Agonist
Proposed duration of therapy Is medicine for PRN use? r Yes r No
Type of pain r Acute r Chronic Severity of pain: r Mild r Moderate r Severe
Is there a history of substance abuse or addiction? r Yes r No
If yes, is treatment plan attached? r Yes r No
Indicate prior and/or current analgesic therapy and alternative management choices
Drug/therapy Reason for d/c
Drug/therapy Reason for d/c
Page 2 Patient Medicaid #
Form 369 Alabama Medicaid Agency
Revised 7-1-15 www.medicaid.alabama.gov
r Xenical
R
r If initial request Weight kg. Height inches BMI kg/m
2
r If renewal request Previous weight kg. Current weight kg.
Documentation MD supervised exercise/diet regimen > 6 mo.? r Yes r No Planned adjunctive therapy? r Yes r No
r Phosphodiesterase Inhibitors
Failure or inadequate response to the following alternate therapies:
1. 2. 3.
4. 5. 6.
Contraindication of alternate therapies:
r Documentation of vasoreactivity test attached r Consultation with specialist attached
r Specialized Nutritionals Height inches Current weight kg.
r If < 21 years of age, record supports that > 50% of need is met by specialized nutrition
r If > 21 years of age, record supports 100% of need is met by specialized nutrition
Method of administration Duration # of rells
r Xolair® Current Weight:__________kg (patient’s weight must be between 30-150kg)
Is the patient 12 years or older? r Yes r No
Is the request for chronic idiopathic urticaria? r Yes r No
Is the request for moderate to severe asthma and is treatment recommended by a board
certied pulmonologist or allergist after their evaluation (if yes answers questions below)? r Yes r No
Has the patient had a positive skin or blood test reaction to a perennial aeroallergen? r Yes r No
Is the patient symptomatic despite receiving a combination of either inhaled corticosteroid
and a leukotriene inhibitor or an inhaled corticosteroid and long acting beta agonist or has
the patient required 3 or more bursts of oral steroids within the past 12 months? r Yes r No
Are the patient’s baseline IgE levels between 30 IU/mL and 700 IU/mL? r Yes r No
Level:_________________ Date:__________________
r Antipsychotic Agents The request is for: r Monotherapy or r Polytherapy
For children < 6 years of age, have monitoring protocols (see Attachment C on the Alabama Medicaid website) been followed? r Yes r No
For polytherapy and/or off-label use, please provide medical justication to support the use of the drug being requested.
Medical justication may include peer reviewed literature, medical record documentation, chart notes with specic symptoms
that the support the diagnosis, etc.